Senanayake S, Gunawardena N, Palihawadana P, Kularatna S, Peiris T. Validity and reliability of the Sri Lankan version of the kidney disease quality of life questionnaire (KDQOL-SF™). Health Qual Life Outcomes. 2017;15(1):119.
Article
PubMed
PubMed Central
Google Scholar
Papanicolas I, Woskie LR, Jha AK. Health care spending in the United States and other high-income countries. JAMA. 2018;319(10):1024–39.
Article
PubMed
Google Scholar
Halton K, Graves N. Economic evaluation and catheter-related bloodstream infections. Emerg Infect Dis. 2007;13(6):815.
Article
PubMed
PubMed Central
Google Scholar
Kularatna S, Whitty JA, Johnson NW, Scuffham PA. Health state valuation in low-and middle-income countries: a systematic review of the literature. Value Health. 2013;16(6):1091–9.
Article
PubMed
Google Scholar
Coyle S, Kinsella S, Lenehan B, Queally J. Cost-utility analysis in orthopaedic trauma; what pays? A systematic review. Injury. 2018;49(3):575–84.
Article
CAS
PubMed
Google Scholar
Devlin N, Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ. 2004;13(5):437–52.
Article
PubMed
Google Scholar
Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010;19(4):422–37.
Article
PubMed
Google Scholar
Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, et al. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet. 2011;378(9789):449–55.
Article
PubMed
Google Scholar
Institue for Health Metrics and Evaluation. Global Burden of Disease Compare 2016. https://vizhub.healthdata.org/gbd-compare/. Accessed 1 Apr 2018.
Australian Institute of Health and Welfare. Health expenditure Australia 2012–13. Canberra; 2014.
Wyld M, Lee C, Zhuo X, White S, Shaw J, Morton R, et al. Cost to government and society of chronic kidney disease stage 1–5: a national cohort study. Internal Med J. 2015;45(7):741–7.
Article
CAS
Google Scholar
Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol. 2009;20(5):1069–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cass A, Chadban S, Gallagher M, Howard K, Jones A, McDonald S, et al. The economic impact of end-stage kidney disease in Australia: Projections to 2020. Melbourne: Kidney Health Aust; 2010.
Google Scholar
Jones-Hughes T, Snowsill T, Haasova M, Coelho H, Crathorne L, Cooper C, et al. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. 2016.
Foster ED, Deardorff A. Open science framework (OSF). J Med Libr Assoc. 2017;105(2):203.
PubMed Central
Google Scholar
Winn AN, Ekwueme DU, Guy GP Jr, Neumann PJ. Cost-utility analysis of cancer prevention, treatment, and control: a systematic review. Am J Prev Med. 2016;50(2):241–8.
Article
PubMed
Google Scholar
Maru S, Byrnes J, Carrington MJ, Stewart S, Scuffham PA. Systematic review of trial-based analyses reporting the economic impact of heart failure management programs compared with usual care. Eur J Cardiovasc Nurs. 2016;15(1):82–90.
Article
PubMed
Google Scholar
Rinaldi G, Hijazi A, Haghparast-Bidgoli H. Cost and cost-effectiveness of mHealth interventions for the prevention and control of type 2 diabetes mellitus: a protocol for a systematic review. BMJ Open. 2019;9(4):e027490.
Article
PubMed
PubMed Central
Google Scholar
de Soarez PC, Silva AB, Randi BA, Azevedo LM, Novaes HMD, Sartori AMC. Systematic review of health economic evaluation studies of dengue vaccines. Vaccine. 2019;37(17):2298–310.
Article
PubMed
Google Scholar
Coyle D, Lee KM. Evidence-based economic evaluation: how the use of different data sources can impact results. Evid Based Health Econ. 2002.
Axelrod DA, Schnitzler MA, Xiao H, Irish W, Tuttle-Newhall E, Chang SH, et al. An economic assessment of contemporary kidney transplant practice. Am J Transplant. 2018;18(5):1168–76.
Article
PubMed
Google Scholar
Barnieh L, Gill JS, Klarenbach S, Manns BJ. The cost-effectiveness of using payment to increase living donor kidneys for transplantation. Clin J Am Soc Nephrol. 2013;8(12):2165–73.
Article
PubMed
PubMed Central
Google Scholar
Bavanandan S, Yap Y-C, Ahmad G, Wong H-S, Azmi S, Goh A. The cost and utility of renal transplantation in Malaysia. Transplant Direct. 2015;1(10):45.
Article
CAS
Google Scholar
Cavallo MC, Sepe V, Conte F, Abelli M, Ticozzelli E, Bottazzi A, et al. Cost-effectiveness of kidney transplantation from DCD in Italy. Transplant Proc. 2014;46(10):3289–96.
Article
CAS
PubMed
Google Scholar
Groen H, Moers C, Smits JM, Treckmann J, Monbaliu D, Rahmel A, et al. Cost-effectiveness of hypothermic machine preservation versus static cold storage in renal transplantation. Am J Transplant. 2012;12(7):1824–30.
Article
CAS
PubMed
Google Scholar
Kadatz M, Klarenbach S, Gill J, Gill JS. Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients. Am J Transplant. 2018;18(10):2457–64.
Article
PubMed
Google Scholar
Kiberd BA. Should hepatitis C-infected kidneys be transplanted in the United States? Transplantation. 1994;57(7):1068–72.
Article
CAS
PubMed
Google Scholar
Liem YS, Kock MCJM, Ijzermans JNM, Weimar W, Visser K, Hunink MGM. Living renal donors: optimizing the imaging strategy—decision- and cost-effectiveness analysis. Radiology. 2003;226(1):53–62.
Article
PubMed
Google Scholar
Matas AJ, Schnitzler M. Payment for living donor (vendor) kidneys: a cost-effectiveness analysis. Am J Transplant. 2004;4(2):216–21.
Article
PubMed
Google Scholar
McLaughlin K, Manns B, Nickerson P. The routine use of high-resolution immunological screening of recipients of primary deceased donor kidney allografts is cost-effective. Transplantation. 2006;81(9):1278–84.
Article
PubMed
Google Scholar
Mutinga N, Brennan DC, Schnitzler MA. Consequences of eliminating HLA-B in deceased donor kidney allocation to increase minority transplantation. Am J Transplant. 2005;5(5):1090–8.
Article
PubMed
Google Scholar
Nguyen HTD, Lim WH, Craig JC, Chapman JR, Lord SJ, Howard K, et al. The relative benefits and costs of solid phase bead technology to detect preformed donor specific antihuman leukocyte antigen antibodies in determining suitability for kidney transplantation. Transplantation. 2015;99(5):957–64.
Article
CAS
PubMed
Google Scholar
Schnitzler MA, Whiting JF, Brennan DC, Lin G, Chapman W, Lowell J, et al. The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation. 2003;75(12):1940–5.
Article
PubMed
Google Scholar
Schweitzer EJ, Perencevich EN, Philosophe B, Bartlett ST. Estimated benefits of transplantation of kidneys from donors at increased risk for HIV or hepatitis C infection. Am J Transplant. 2007;7(6):1515–25.
Article
CAS
PubMed
Google Scholar
Smith JM, Schnitzler MA, Gustafson SK, Salkowski NJ, Snyder JJ, Kasiske BL, et al. Cost Implications of New National Allocation Policy for Deceased Donor Kidneys in the United States. Transplantation. 2016;100(4):879–85.
Article
PubMed
Google Scholar
Snyder RA, Moore DR, Moore DE. More donors or more delayed graft function? A cost-effectiveness analysis of DCD kidney transplantation. Clin Transplant. 2013;27(2):289–96.
Article
PubMed
Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.
Article
Google Scholar
The World Bank. Italy: The World Bank,; 2018. https://data.worldbank.org/country/italy. Accessed 6 Sept 2018.
The World Bank. Low & middle income countries: The World Bank, 2018. https://data.worldbank.org/income-level/low-and-middle-income. Accessed 6 Sept 2018.
Geraci PM, Sepe V. Non-heart-beating organ donation in Italy. Minerva Anestesiol. 2011;77(6):613–23.
CAS
PubMed
Google Scholar
Marciante KD, Veenstra DL, Lipsky BA, Saint S. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use. Am J Infect Control. 2003;31(1):1–8.
Article
PubMed
Google Scholar
Jain R, Grabner M, Onukwugha E. Sensitivity analysis in cost-effectiveness studies. Pharmacoeconomics. 2011;29(4):297–314.
Article
PubMed
Google Scholar
Rosen AB, Greenberg D, Stone PW, Olchanski NV, Neumann PJ. Quality of abstracts of papers reporting original cost-effectiveness analyses. Med Decis Making. 2005;25(4):424–8.
Article
PubMed
Google Scholar
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Cost Effect Resour Alloc. 2013;11(1):6.
Article
Google Scholar
Ten Jönsson B. arguments for a societal perspective in the economic evaluation of medical innovations. New York: Springer; 2009.
Google Scholar
Cheng Q, Graves N, Pacella RE. Economic evaluations of guideline-based care for chronic wounds: a systematic review. Appl Health Econ Health Policy. 2018;16(5):633–51.
Article
PubMed
Google Scholar
Gervès-Pinquié C, Girault A, Phillips S, Raskin S, Pratt-Chapman M. Economic evaluation of patient navigation programs in colorectal cancer care, a systematic review. Health Econ Rev. 2018;8(1):12.
Article
PubMed
PubMed Central
Google Scholar
Eeren HV, Schawo SJ, Scholte RH, Busschbach JJ, Hakkaart L. Value of information analysis applied to the economic evaluation of interventions aimed at reducing juvenile delinquency: an illustration. PLoS ONE. 2015;10(7):e0131255.
Article
PubMed
PubMed Central
CAS
Google Scholar
Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices—budget impact analysis. Value Health. 2007;10(5):336–47.
Article
PubMed
Google Scholar
Kamar N, Marion O, Rostaing L, Cointault O, Ribes D, Lavayssière L, et al. Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation. Am J Transplant. 2016;16(5):1474–9.
Article
CAS
PubMed
Google Scholar
Sawinski D, Kaur N, Ajeti A, Trofe-Clark J, Lim M, Bleicher M, et al. Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents. Am J Transplant. 2016;16(5):1588–95.
Article
CAS
PubMed
Google Scholar
Somerville L, Doucette K. Hepatitis C: current controversies and future potential in solid organ transplantation. Curr Infect Dis Rep. 2018;20(7):18.
Article
PubMed
Google Scholar
Reese PP, Abt PL, Blumberg EA, Goldberg DS. Transplanting hepatitis C-positive kidneys. New Engl J Med. 2015;373(4):303.
Article
CAS
PubMed
Google Scholar
Van Pilsum Rasmussen SE, Henderson ML, Bollinger J, Seaman S, Brown D, Durand CM, et al. Perceptions, motivations, and concerns about living organ donation among people living with HIV. AIDS care. 2018;30(12):1595–9.
Article
PubMed
PubMed Central
Google Scholar
Boyarsky BJ, Hall EC, Singer AL, Montgomery RA, Gebo KA, Segev DL. Estimating the potential pool of HIV-infected deceased organ donors in the United States. Am J Transplant. 2011;11(6):1209–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schold JD, Segev DL. Increasing the pool of deceased donor organs for kidney transplantation. Nat Rev Nephrol. 2012;8(6):325.
Article
CAS
PubMed
Google Scholar
Pope TM. Legal briefing: organ donation and allocation. J Clin Ethics. 2010;21(3):243–63.
PubMed
Google Scholar
Danovitch GM, Delmonico FL. The prohibition of kidney sales and organ markets should remain. Cur Opin Organ Transplant. 2008;13(4):386–94.
Article
Google Scholar
Mayrhofer-Reinhartshuber D, Fitzgerald A, Fitzgerald RD. Money for consent–psychological consideration. Ann Transplant. 2005;10(1):26–9.
PubMed
Google Scholar
Curtis J. Ageism and kidney transplantation. Am J Transplant. 2006;6(6):1264–6.
Article
CAS
PubMed
Google Scholar
Ladin K, Hanto DW. Rational rationing or discrimination: balancing equity and efficiency considerations in kidney allocation. Am J Transplant. 2011;11(11):2317–21.
Article
CAS
PubMed
PubMed Central
Google Scholar